OpenFederal grantOpen to for-profit businessesRFA-DA-26-034

Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)

National Institutes of HealthCloses Nov 18, 2027(401 days left)Up to $300,000

Does this fit your business?

This is an NIH basic research grant for studying the acute and delayed harmful effects of ultra-potent synthetic opioids like fentanyl, carfentanil, nitazenes, and fentanyl-xylazine mixes. It fits research-driven organizations, mainly in healthcare and biotech; retail, finance, transportation, and other businesses with no research function should not bother applying. Foreign entities are ineligible.

Best for
Universities and academic research labs, Nonprofits with biomedical research capacity, Small businesses doing opioid-related R&D, State, local, and tribal government research programs
Not for
Retail, finance, and logistics businesses with no research function, Foreign entities and non-U.S. components of U.S. organizations, Organizations looking for operating or commercialization funding rather than research grants
Estimated fit by industry, best first
IndustryEstimated fit
Healthcare & BiotechMatches your industry (clinical)
68
Good Match
Arts & CultureLimit: Not clearly about your industry or what you need funding for; check the…
54
Possible Match
Education & TrainingLimit: Not clearly about your industry or what you need funding for; check the…
54
Possible Match
Energy & Clean TechLimit: Nothing in this notice points to energy & clean tech
54
Possible Match
Environment & ConservationLimit: Nothing in this notice points to environment & conservation
54
Possible Match
Housing & Real EstateLimit: Nothing in this notice points to housing & real estate
54
Possible Match
Show all 15 industries
Estimated fit by industry, best first
IndustryEstimated fit
Social Services & NonprofitLimit: Nothing in this notice points to social services & nonprofit
54
Possible Match
Technology & SoftwareLimit: Nothing in this notice points to technology & software
54
Possible Match
Agriculture & FarmingLimit: Nothing in this notice points to agriculture & farming
51
Possible Match
ManufacturingLimit: Nothing in this notice points to manufacturing
51
Possible Match
Food & BeverageLimit: Nothing in this notice points to food & beverage
50
Possible Match
Construction & InfrastructureLimit: Nothing in this notice points to construction & infrastructure
49
Possible Match
Finance & BankingLimit: Nothing in this notice points to finance & banking
49
Possible Match
Retail & E-CommerceLimit: Nothing in this notice points to retail & e-commerce
49
Possible Match
Transportation & LogisticsLimit: Nothing in this notice points to transportation & logistics
49
Possible Match

These are our matcher’s estimates for a typical business in each industry. A real match depends on your size, your state and what you need the money for — check your own fit.

What this funds

Money can be used for
Research
Who can apply
Small businesses, For-profit companies, Nonprofits, State and local governments, Tribal governments and organizations, Colleges and universities, Other applicants (see eligibility)
Award range
Up to $300,000

Questions about this grant

When is the application deadline?
November 18, 2027.
How much funding can an applicant receive?
The largest award is $300,000, and total program funding is also listed at $300,000.
Who can apply for this grant?
Universities, nonprofits (with or without 501(c)(3) status), small businesses, other for-profits, state, county, city and special district governments, public housing authorities, independent school districts, and federally recognized or other Native American tribal governments and organizations. Foreign entities and non-domestic components of U.S. organizations are not eligible.
Can a sole proprietor or single-member LLC apply?
The facts do not say. Sole proprietors are not listed among the eligible applicant types, so check the full notice on Grants.gov before assuming you qualify.
Can a nonprofit apply?
Yes. Nonprofits with 501(c)(3) status, nonprofits without 501(c)(3) status (other than institutions of higher education), and private or public institutions of higher education may all apply.

Summary

NIH R01 research grants to study the harmful acute and delayed effects of ultra-potent synthetic opioids such as fentanyl, carfentanil, nitazenes and fentanyl-xylazine combinations. Open to universities, nonprofits, state/local/tribal governments, small businesses and other for-profits; foreign entities are ineligible. Awards up to $300,000.

About this grant

This notice of funding opportunity (NOFO) will support research towards understanding and mitigating the deleterious effects of acute exposure to Ultra-Potent Synthetic (UPS) opioids (e.g., fentanyl, carfentanil, nitazenes) and their combinations (fentanyl and xylazine). This NOFO will also support research on the persistent and/or delayed pathophysiological effects after acute exposure to such agents.

Who can apply

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.

Topics and uses of funds

Topics

  • Health
  • Science
  • Defense

Program contact

National Institutes of Healthgrantsinfo@nih.gov301-402-2541

Open opportunities funding similar work, from the same funder or in the same place.